Together, these data demonstrate that expression of rate-limiting glucose and fructose metabolism genes, including KHK-C, are induced in hypoxic conditions as well as Kras/p53-driven pancreatic cancers of mice and humans. The gene discussed is KRAS; the disease is pancreatic neoplasm.